APA (7th ed.) Citation

KC, B., ME, M., CJ, L., MJ, M., WJ, M., BC, G., . . . C, E. (2020). An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer. Thyroid : official journal of the American Thyroid Association, 30(9), 1254. https://doi.org/10.1089/thy.2019.0269

Chicago Style (17th ed.) Citation

KC, Bible, et al. "An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer." Thyroid : Official Journal of the American Thyroid Association 30, no. 9 (2020): 1254. https://doi.org/10.1089/thy.2019.0269.

MLA (9th ed.) Citation

KC, Bible, et al. "An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer." Thyroid : Official Journal of the American Thyroid Association, vol. 30, no. 9, 2020, p. 1254, https://doi.org/10.1089/thy.2019.0269.